Abstract:Abstract Recent studies showed that somatic cancer mutations target genes that are in specific signaling and cellular pathways. However, in each patient only a few of the pathway genes are mutated. Current approaches consider only existing pathways and ignore the topology of the pathways. For this reason, new efforts have been focused on identifying significantly mutated subnetworks and associating them with cancer characteristics. We applied two well-established network analysis approaches to identify significantly mutated subnetworks in the breast cancer genome. We took network topology into account for measuring the mutation similarity of a gene-pair to allow us to infer the significantly mutated subnetworks. Our goals are to evaluate whether the identified subnetworks can be used as biomarkers for predicting breast cancer patient survival and provide the potential mechanisms of the pathways enriched in the subnetworks, with the aim of improving breast cancer treatment. Using the copy number alteration (CNA) datasets from the METABRIC (Molecular Taxonomy of Breast Cancer International Consortium) study, we identified a significantly mutated yet clinically and functionally relevant subnetwork using two graph-based clustering algorithms. The mutational pattern of the subnetwork is significantly associated with breast cancer survival. The genes in the subnetwork are significantly enriched in retinol metabolism KEGG pathway. Our results show that breast cancer treatment with retinoids may be a potential personalized therapy for breast cancer patients since the CNA patterns of the breast cancer patients can imply whether the retinoids pathway is altered. We also showed that applying multiple bioinformatics algorithms at the same time has the potential to identify new network-based biomarkers, which may be useful for stratifying cancer patients for choosing optimal treatments.

Network-based Identification of novel cancer genes

CancerNet: a Database for Decoding Multilevel Molecular Interactions Across Diverse Cancer Types

Enhancing Cancer Driver Gene Prediction by Protein-Protein Interaction Network

Discovery of Pan-Cancer Related Genes Via Integrative Network Analysis.

Network-Based Inference Framework for Identifying Cancer Genes from Gene Expression Data

Network‐based Integration Method for Potential Breast Cancer Gene Identification

Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes

An Efficient and Easy-to-Use Network-Based Integrative Method of Multi-Omics Data for Cancer Genes Discovery

Discovering Potential Cancer Driver Genes by an Integrated Network-Based Approach.

Identifying Key Genes in Cancer Networks Using Persistent Homology

Highly parallel identification of essential genes in cancer cells

Identification of Genes Associated with Breast Cancer Metastasis to Bone on A Protein-Protein Interaction Network with A Shortest Path Algorithm

Identification of Novel Cancer-Related Genes with a Prognostic Role Using Gene Expression and Protein-Protein Interaction Network Data.

OPMSP: A Computational Method Integrating Protein Interaction and Sequence Information for the Identification of Novel Putative Oncogenes

Discovery of novel therapeutic targets in cancer using patient-specific gene regulatory networks

The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens

Inferring Novel Tumor Suppressor Genes with a Protein-Protein Interaction Network and Network Diffusion Algorithms

Identification of significantly mutated subnetworks in the breast cancer genome

A human functional protein interaction network and its application to cancer data analysis

Predicating Candidate Cancer-Associated Genes in the Human Signaling Network Using Centrality

A novel heterophilic graph diffusion convolutional network for identifying cancer driver genes